Dr. Ben Medrano is a board certified psychiatrist specializing in Integrative Psychiatry, Ketamine Assisted Therapy and Psychedelic Harm Reduction and Integration. He received his MD from the University of Colorado School of Medicine with additional training in their Urban Underserved Track. He completed his psychiatric residency training within the Mount Sinai Hospital system in New York City and spent years working for the urban underserved particularly in East Harlem Assertive Community Treatment performing daily home visits for high risk consumers before focusing on the use of psychedelics in mental health.

He’s a graduated fellow in Integrative Psychiatry through the Integrative Psychiatry Institute’s Fellowship where he also received additional training through their Ketamine for Medical Providers program with sponsorship and certification from the American Society of Ketamine Physicians. He has trained with numerous leaders in the field of ketamine assisted therapy, including Phil Wolfson, MD and has joined him in leading clinician education at The Ketamine Training Center.

His clinical practice has been strongly influenced by an ongoing interest in consciousness, psychedelics, and integrative medicine. He is a graduate of Vajrayana Buddhist seminary and is a rigorously trained meditation instructor with over 20 years of ongoing intensive training. He continues to study psychedelic therapy modalities within the community of senior students of Ralph Metzner, PhD who was a leader in the field of consciousness expanding therapies.

Dr. Medrano is most known for his work with ketamine assisted therapy and was the national Medical Director of Field Trip Health - one of the largest in-office ketamine assisted therapy practices to date. Following this he served as Chief Medical Officer at Nue.Life a large scale home-based ketamine assisted therapy and integrative mental health provider. He continues to supervise a variety of clinics on the East Coast allowing him to further the field of psychedelic assisted therapy and research.

In addition to multiple conference speaking engagements, he lectures on the utility of ketamine and psychedelics for mental health at Naropa University. He currently serves on the HealingMaps.com Medical Advisory. His work, insight and advice have been covered in a number of articles including The New York Times, The New Yorker, Forbes, Business Insider, The New York Post, Cheddar, Bloomberg, The Houston Chronicle, HealthLine, VeryWellMind, YahooFinance, The Dales Report, The Zoe Report, and numerous others.

• University of Colorado Denver School of Medicine, Denver CO

  • Doctor of Medicine

  • CU-UNITE (Colorado Urban Underserved Inter-professional Health Training and Education)

  • Urban Underserved Medical Student Track Graduate

• University of Colorado Denver, Denver CO

  • Bachelor of Sciences in Biology

• Naropa University, Boulder CO

  • Contemplative Psychology Major

• Ketamine Medical Providers Training, Boulder CO

  • Integrative Psychiatry Institute & ASKP3

• Integrative Psychiatry Institute Fellowship, Boulder CO

  • Integrative Psychiatry Institute

• Ketamine Assisted Therapy Intensive, Phoenicia NY

  • Ketamine Training Center with Phil Wolfson, MD

• Ketamine Assisted Therapy for Clinicians, Toronto ON

  • GROF Legacy Training Faculty

• Ketamine for Clinicians, New York NY

  • Fluence (Formerly Center for Optimal Living)

• Introduction to Ketamine Psychotherapy, New York NY

  • Horizons Annual Conference

• Psychedelics for Clinicians 101 & 102, New York NY

  • Fluence (Formerly Center for Optimal Living)

• Center for Practice Innovations at Columbia University, New York, NY

  • Assertive Community Treatment Core Curriculum

• New York Psychoanalytic Institute, New York, NY

  • Psychoanalytic Fellowship Program

• Mount Sinai Hospitals (Beth Israel) New York NY

  • Resident Physician, Department of Psychiatry

• American Board of Psychiatry and Neurology Certificate #74542

• United States Medical Licensing Exam, Step 1, 2, 3: PASS

• State of Colorado, Medical License #DR.0067127
  

• State of Connecticut, Medical License #69516
  

• State of Delaware, Medical License #C1-0025647
  

• District of Columbia, Medical License #20000013
  

• State of Florida, Medical License #ME165679
  

• State of Georgia, Medical License #94442
  

• State of Massachusetts, Medical License #295544
  

• State of New Jersey Medical License #25MA11981100
  

• State of New York, Medical License #284877
  

• State of Pennsylvania, Medical License #MD483026
  

• State of Virginia, Medical License #101280891

• DEA Registration, Practitioner #XM6702814

• Clozapine REMS Registry, Prescriber

• Spravato REMS Registry, Prescriber

• Psychedelic Medicine Association, Member

• President's Scholarship (4 years full tuition), University of Colorado School of Medicine

• Adler Research Scholar Award, University of Colorado School of Medicine
  

• Medical Alumni Association Award, University of Colorado School of Medicine

• English

• 13

• April 23, 2023 (Preprint)
  Yermus R, Verbora M, Kennedy S, McMaster R, Kratina S, RN, Wolfson E, Medrano B, Bryson N,
  Zaer N, Bottos J, Setlur V, Lo C. Ketamine-assisted psychotherapy provides lasting and effective
  results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months:
  Findings from a large single-arm retrospective effectiveness trial. J Psychedelic Medicine (currently
  under peer review). Submitted Aug 2023
  
  

• January 1, 2022 - Present
  Principal Investigator
  Feasibility of Ketamine-Assisted Psychotherapy as an Adjunctive Treatment to Relieve Distress in
  Patients Receiving Palliative Radiation Therapy
  The Feinstein Institutes for Medical Research obo Northwell Health, Inc & Stella/Field Trip Health, New York, NY
  
  

• May 24, 2018
  Psychiatry Grand Rounds Literature Review and Presentation
  Mindfulness and Physician Burnout: Literature review and resident intervention review.
  Mount Sinai Hospitals, New York, NY
  
  

• July 26, 2016
  Bassir NA, Medrano B, Perkel C, Galynker I, Hurd YL. Psychiatric comorbidity associated with
  synthetic cannabinoid use compared to cannabis. J Psychopharmacol. 2016;3012:1321–30.Arch
  Environ Occup Health 2016
  
  

• February 1, 2011 - December 31, 2016
  Co-Principal Investigator
  The MCAT Cooperative, Pilot Program: Eliminating financial barriers for students
  underrepresented in health care.
  University of Colorado School of Medicine, Denver CO